Clinical Trials Logo

Metabolism clinical trials

View clinical trials related to Metabolism.

Filter by:

NCT ID: NCT01121003 Completed - Metabolism Clinical Trials

Effects of Fructose and Exercise on Hepatic Lipid Metabolism

FRUCTEXER
Start date: May 2010
Phase: N/A
Study type: Interventional

8 healthy male volunteers will be studied each on 3 occasions, ie - after 4 days on a weight maintenance diet containing 5% simple sugars + low physical activity - after 4 days on a weight maintenance diet containing 30% fructose + low physical activity - after 4 days on a weight maintenance diet containing 30% fructose + high physical activity At the end of each of these 3 periods, fructose induced hepatic de novo lipogenesis (13C palmitate synthesis in response to ingestion of a 13C fructose load) and plasma VLDL-triglyceride kinetics (measured with a bolus of 2H-labeled glycerol) will be measured

NCT ID: NCT01082146 Completed - Pharmacokinetics Clinical Trials

RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE

Start date: August 2008
Phase: Phase 1
Study type: Interventional

This will be an open-label, non-randomized, absorption, metabolism, and excretion study of Lurasidone administered in a suspension at 40 mg to 6 normal healthy male subjects in a postprandial state

NCT ID: NCT01041820 Completed - Metabolism Clinical Trials

Critical Periods of Exercise

Start date: December 2009
Phase: N/A
Study type: Interventional

Early childhood (~3-7 years of age) is an important window for determining body composition trajectory and may be a critical period for the development of tissue partitioning patterns that influence obesity risk. As adiposity accelerates during this critical period, deposition/ preservation of fat stores may be sustained at the 'expense' of other tissues; i.e. energy homeostasis may be inherently biased toward fat gain. The type and amount of tissue mass accrued in early childhood has implications for metabolic profile, glucose/insulin homeostasis, hormone profile and resting energy expenditure. The interplay between fat and bone deposition represents a physiologic trait enabling the body to choose between shuttling 'energy' towards accrual of a particular tissue. Plausibly the phenotype underlying obesity and diabetes risk may be determined by the differentiation of cell type (adipocyte, osteocyte, etc.) during this early stage of growth and development. In vitro studies demonstrate transdifferentiation under the influence of specific external stimuli, which can switch phenotypes toward other cell lineages. Further, rodent models have demonstrated that exposure to stimuli (exercise) early in life may prevent excess fat mass accrual in adulthood, even when the stimulus is later removed (animals are no longer exercising). Children's early experiences (engagement in physical activity vs. sedentary behavior) may 'environmentally induce' alterations in body composition and predispose individuals to obesity throughout life. Aim 1. To examine the associations between body composition via DXA and objectively-measured physical activity/inactivity. 1. Hypothesis 1.1: There is a positive association between physical activity and bone mass. 2. Hypothesis 1.2: There is a positive association between sedentary behavior and total fat mass. Aim2. To examine the associations between adipose tissue distribution via MRI and objectively-measured physical activity/inactivity. 3. Hypothesis 2.1: There is an inverse association between physical activity and bone marrow adipose tissue. 4. Hypothesis 2.2: There is a positive association between sedentary behavior and bone marrow adipose tissue.

NCT ID: NCT01041664 Completed - Body Composition Clinical Trials

Bad Genes or Genes Behaving Badly

Start date: December 2009
Phase:
Study type: Observational

A key factor in the determination of body composition over the lifecourse is fat accumulation during childhood. Periods of life associated with the greatest changes in organ development and growth, i.e. early childhood, have the most significant effect on body composition, energy balance, and metabolism. Early childhood (age 3 to 7 years) represents a critical transition for the basis of adaptability in body composition, due to the rapid growth and development that occurs. Plausibly the phenotype underlying obesity and related health risk may be determined by body composition during this critical period. Our previous research in children has consistently indicated that HA children accumulate greater amounts of fat, particularly in the intra-abdominal compartment, even at similar a BMI, and lower bone mineral content relative to EA children. The reason for these differences in body composition over the lifecourse is not clear. Racial/ethnic differences in risk factors for health, including 'thriftiness' in body fat accumulation are often evident before the age of 7, suggesting that the racial/ethnic differences in energy utilization and subsequent fat storage may be accounted for by genetic make-up, the environment (e.g. diet), or an interaction of the two. The physiologic or behavioral process(es) that cause(s) certain children to take a trajectory towards obesity while others accrue less fat is not known. However, the economic decision of fuel utilization is a physiologic trait enabling the body to choose between shuttling 'energy' towards accrual of a particular tissue (e.g. bone vs. fat) and this trait likely has a genetic component. This genetic component may be embedded in fat storage capacity evolved from gene by environment interactions that promote thrift, particularly conserved in some populations. Although genetic background plays a role, it not known whether there is a relationship between genetic background, known candidate genes or candidate pathways and environmental contributors (e.g. diet) that impact body composition trajectory. Of central importance to our understanding of early fat mass accumulation in health disparities are the mechanisms that lead to chronic disease progression. It is likely that variations within candidate genes may have a differential impact on individuals based on their genetic background. It is also probable that body composition is influenced by many genes, often within the same metabolic pathways, with small individual effects. These genes may not be significantly associated individually, but when examined as a unit (in a candidate pathway or gene-gene interaction framework) the association becomes significant. Further, children's early environmental exposures (e.g. diet) may interact with both genetic background and variations in candidate genes along resulting in alterations in body composition that predispose HA to excess fat accumulation throughout the lifecourse. To that end, the following specific aims will be evaluated: Aim 1. To examine the associations between genetic admixture and body composition in children aged 3-7 years after controlling for dietary intake. 1. Hypothesis 1.1: There is a direct association between Amerindian admixture and fat mass and in inverse association between Amerindian admixture and bone mass. 2. Hypothesis 1.2: There is a direct association between energy intake and fat accumulation and the relationship will be particularly evident in individuals with a greater proportion of Amerindian admixture. Aim 2. To examine the associations between genetic admixture and bone marrow fat in children aged 3-7 years after controlling for dietary intake. 1. Hypothesis 2.1: There is a direct association between Amerindian admixture and bone marrow fat. 2. Hypothesis 2.2: There is a direct association between energy intake and fat accumulation in bone marrow and the relationship will be particularly evident in individuals with a greater proportion of Amerindian admixture. Aim 3. To examine the relationship between variation in candidate genes and pathways and Amerindian admixture controlling for dietary intake. a. Hypothesis 3.1: Amerindian admixture will be associated with variations in candidate genes and pathways known to be associated with fat accumulation.

NCT ID: NCT00940641 Suspended - Metabolism Clinical Trials

Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration

Start date: August 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the absorption, distribution, metabolism and excretion of AZD7325 after intravenous and 14C labeled oral dose

NCT ID: NCT00881062 Completed - METABOLISM Clinical Trials

Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females

Start date: April 2009
Phase: Phase 1
Study type: Interventional

This study was to determine the ADME and metabolites of Proellex following a single oral dose of 25 mg.

NCT ID: NCT00791869 Completed - Pharmacokinetics Clinical Trials

Pharmacogenetics of Bupropion Metabolism

Start date: June 2008
Phase: N/A
Study type: Observational

The aim of the investigators research is to see if variants in a particular gene (named CYP2B6) affect how the body metabolizes (breaks down) certain medications, including the drug bupropion. Bupropion is widely used in the treatment of depression and for helping people quit smoking. Genes are portions of DNA that code for particular proteins in the body. The investigators are studying the gene that codes for a protein called CYP2B6. Differences in the structure of the gene are called variants and may mean that a person metabolizes a drug faster or slower than a person with a different variant.

NCT ID: NCT00722696 Not yet recruiting - Metabolism Clinical Trials

Metabolic Effects of Eccentric Endurance Training

Start date: July 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate metabolic parameters in previously sedentary individuals before and after eccentric endurance training (hiking downwards). Study participants will regularly hike downwards over a difference in altitude of 540 meters during 8 weeks. For the opposite way, a cable car will be used. Metabolic profiles will be obtained at baseline and after the 8 weeks period of eccentric endurance exercise.

NCT ID: NCT00714675 Completed - Elderly Clinical Trials

Citrulline and Protein Metabolism in the Malnourished Elderly People

CIPROAGE
Start date: December 2009
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effects of a supplementation of citrulline for three weeks in elderly malnourished and hospitalised subjects on muscle protein synthesis.

NCT ID: NCT00692510 Completed - Alzheimer's Disease Clinical Trials

Drug Interaction Study Between AZD3480 and Cytochrome P450

Cocktail
Start date: November 2007
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate if AZD3480 inhibits Cytochrome P450 1A2, 2C19, 3A4, 2C8, 2B6 and UGT1A1 activity.